内部人交易雷达

美国 · SEC Form 4 · 快照日期： 2026-10-19 · 构建时间： 2026-10-19 · English

← 美国市场 · 覆盖记录

美国 · SEC FORM 4

CG Oncology, Inc.

CGON · Nasdaq · CIK 0001991792 · Healthcare · Biotechnology

内部人信号

61.1 / 100

1 位买方 · 1 条买入交易行 · $24.8M 买入总额

为什么有这个信号？

买方广度较低
买入规模较强
角色较强
近期性较低
确信度较强
评分构成

每条进度条表示其对当前分数的贡献；权重和公式保持不变。

Cluster+7.0 / 35
买入规模+23.9 / 25
角色+20.0 / 20
近期性+1.4 / 10
确信度+8.8 / 10

哪些因素限制了当前分数？

  • ⚠ Cluster breadth is moderate · 1 insider(s), not 4+
  • ⚠ Purchase activity is becoming less recent
  • ✓ 角色得分高 · 买入者中职位最高的是：Director

Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.

US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后，不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。

买方广度与集中度

合资格买方1
买入集中度100%最大买方： Liu Brian Guan-Chyun · $24.8M
聚集买入 · 15天1 insider峰值活动： 2026-06-25–2026-06-25

Roles in the peak window: Director. Concentration uses priced qualifying P lines only and does not change the saved score.

内部人活动时间轴

申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。

AprMayJunJulAugSepOct
POST LEONARD EDirector
○▼○▼○▼○▼○▼○▼
Mulay JamesDirector
○▼○▼
Liu Brian Guan-ChyunDirector
●
● 买入▼ 卖出○ 其他

—

信号历史

61.1 / 100

最新留档分数

→ +0.0 pts相对上一个留档快照
  1. 60.8
  2. 61.2
  3. 61.2
  4. 61.1
  5. 61.1

Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.

近期 Form 4 活动

1买入
15卖出
19其他 Form 4 交易行
15SEC 申报 · 365天
买入1 qualifying P line(s) · 180 days
卖出9 sale line(s) · 仅供背景
其他9 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

市场背景

市场背景补充近期价格表现与风险信息，不影响内部人信号。

价格表现

1M
-11.4%
3M
-12.0%
6M
-5.7%
12M
+56.8%

波动率与流动性

波动率
61.3%
Beta
—
平均每日成交额
USD 56.1M

估值

市值
USD 5.7B
P/E
—

基本面

利润率
—
ROE
-21.4%
细分行业
Biotechnology

市场数据

价格数据截至：2026-10-11 · 价格来源：OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance) · 来自 SEC 申报文件：市值, ROE · 财年截止日：2025-12-31 · 市值 = 申报文件封面所列的已发行股数 × 最新收盘价。股数日期：2026-08-05 · Status: PASS

空头余额

空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。

空头股数
10,441,484
上期报告
11,254,500
日均成交量
1,234,894
回补天数
8.5

FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。

历史股票买入

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting owner类型证券股数平均价格估算金额来源
2026-06-25Liu Brian Guan-Chyun买入 (P)Common Stock371,085USD 66.87USD 24,814,454SEC 申报 ↗
2025-09-11Liu Brian Guan-Chyun买入 (P)Common Stock1,515,151USD 33.00USD 49,999,983SEC 申报 ↗
2024-01-29Cui Xiangmin; Decheng Capital Global Healthcare Fund (Master), LP; Decheng Capital Global Healthcare GP, LLC; Decheng Capital Global Life Sciences Fund IV, L.P.; Decheng Capital Management IV (Cayman), LLC买入 (P)Common Stock400,000USD 19.00USD 7,600,000SEC 申报 ↗
2024-01-29Song Hong Fang买入 (P)Common Stock263,157USD 19.00USD 4,999,983SEC 申报 ↗
2024-01-29Roche Corleen M.买入 (P)Common Stock2,000USD 19.00USD 38,000SEC 申报 ↗
2024-01-29Kasturi Vijay买入 (P)Common Stock1,315USD 19.00USD 24,985SEC 申报 ↗
2024-01-29Cui Xiangmin; Decheng Capital Global Healthcare Fund (Master), LP; Decheng Capital Global Healthcare GP, LLC; Decheng Capital Global Life Sciences Fund IV, L.P.; Decheng Capital Management IV (Cayman), LLC买入 (P)Common Stock400,000USD 19.00USD 7,600,000SEC 申报 ↗

Form 4 申报证据

35 transaction lines in the latest 365-day window; 90 in local history.

日期申报人类型证券股数平均价格估算金额来源
2026-09-15POST LEONARD E卖出 (S)Common Stock1,000USD 72.98USD 72,980SEC 申报 ↗
2026-09-15POST LEONARD E期权行权／转换 (M)Common Stock1,000USD 0.60USD 600SEC 申报 ↗
2026-08-14POST LEONARD E卖出 (S)Common Stock1,000USD 74.54USD 74,540SEC 申报 ↗
展开近期 Form 4 证据 (29 grouped rows)
日期申报人类型证券股数平均价格估算金额来源
2026-09-15POST LEONARD E卖出 (S)Common Stock1,000USD 72.98USD 72,980SEC 申报 ↗
2026-09-15POST LEONARD E期权行权／转换 (M)Common Stock1,000USD 0.60USD 600SEC 申报 ↗
2026-08-14POST LEONARD E卖出 (S)Common Stock1,000USD 74.54USD 74,540SEC 申报 ↗
2026-08-14POST LEONARD E期权行权／转换 (M)Common Stock1,000USD 0.60USD 600SEC 申报 ↗
2026-07-15POST LEONARD E卖出 (S)Common Stock1,000USD 71.17USD 71,170SEC 申报 ↗
2026-07-15POST LEONARD E期权行权／转换 (M)Common Stock1,000USD 0.60USD 600SEC 申报 ↗
2026-07-10Mulay James卖出 (S)Common Stock24,165USD 75.16USD 1,816,241SEC 申报 ↗
2026-07-10Mulay James期权行权／转换 (M)Common Stock24,165USD 26.63USD 643,514SEC 申报 ↗
2026-06-25Liu Brian Guan-Chyun买入 (P)Common Stock371,085USD 66.87USD 24,814,454SEC 申报 ↗
2026-06-24POST LEONARD E卖出 (S)Common Stock5,000USD 70.00USD 350,000SEC 申报 ↗
2026-06-24POST LEONARD E期权行权／转换 (M)Common Stock5,000USD 0.60USD 3,000SEC 申报 ↗
2026-06-22POST LEONARD E卖出 (S)Common Stock5,000USD 65.00USD 325,000SEC 申报 ↗
2026-06-22POST LEONARD E期权行权／转换 (M)Common Stock5,000USD 0.60USD 3,000SEC 申报 ↗
2026-06-15Mulay James卖出 (S)Common Stock1,964USD 60.12USD 118,076SEC 申报 ↗
2026-06-15Mulay James期权行权／转换 (M)Common Stock1,964USD 9.64USD 18,926SEC 申报 ↗
2026-06-04POST LEONARD E卖出 (S)Common Stock1,000USD 54.50USD 54,500SEC 申报 ↗
2026-06-04POST LEONARD E期权行权／转换 (M)Common Stock1,000USD 0.60USD 600SEC 申报 ↗
2026-04-17Mulay James卖出 (S)Common Stock15,600USD 73.01USD 1,138,956SEC 申报 ↗
2026-04-17Mulay James期权行权／转换 (M)Common Stock15,600USD 36.63USD 571,428SEC 申报 ↗
2026-03-16Mulay James卖出 (S)Common Stock1,964USD 63.50USD 124,714SEC 申报 ↗
2026-03-16Mulay James期权行权／转换 (M)Common Stock1,964USD 9.64USD 18,926SEC 申报 ↗
2026-03-12Kuan Arthur期权行权／转换 (M)Common Stock64,612USD 1.72USD 111,133SEC 申报 ↗
2026-03-12Kuan Arthur代扣税 (F)Common Stock1,847USD 60.15USD 111,097SEC 申报 ↗
2026-03-04Kuan Arthur期权行权／转换 (M)Common Stock102,871USD 1.72USD 176,938SEC 申报 ↗
2026-03-04Kuan Arthur代扣税 (F)Common Stock2,871USD 61.61USD 176,882SEC 申报 ↗
2026-01-09Mulay James卖出 (S)Common Stock11,145USD 52.47USD 584,799SEC 申报 ↗
2026-01-09Mulay James期权行权／转换 (M)Common Stock11,145USD 12.07USD 134,515SEC 申报 ↗
2025-11-17POST LEONARD E卖出 (S)Common Stock1,000USD 41.43USD 41,430SEC 申报 ↗
2025-11-17POST LEONARD E期权行权／转换 (M)Common Stock1,000USD 0.60USD 600SEC 申报 ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

快照与身份

快照日期2026-10-19
排名版本US-v1.2
数据质量PASS ELIGIBLE · —
股票代码CGON
CIK0001991792
行业Healthcare
细分行业Biotechnology Yahoo Finance
SEC SIC2836 Biological Products, (No Diagnostic Substances)
交易所Nasdaq

数据覆盖

本地 Form 4 历史90 transaction lines from 2024-01-29 to 2026-09-15
7 P purchase lines · 43 S sale lines · 40 other lines
SEC 公司申报打开 SEC 申报 ↗

Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.